The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Balabanova V.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Voronina E.O.

Sechenov First Moscow State Medical University, Moscow, Russia

The differential diagnosis and treatment of depressive disorders in climacteric transition

Authors:

Tiuvina N.A., Balabanova V.V., Voronina E.O.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3): 22‑27

DOI: 10.17116/jnevro20171173122-27

Views: 7523

Downloaded: 161

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Tiuvina NA, Balabanova VV, Voronina EO. The differential diagnosis and treatment of depressive disorders in climacteric transition. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3):22‑27. (In Russ.)
https://doi.org/10.17116/jnevro20171173122-27

 
МСФ на ЯМ
Close metadata
Recommended articles:
The asso­ciation of poly­morphisms of the sero­tonin transporter gene SLC6A4 with depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):135-139
Possibilities of dyna­mic phase contrast MRI of cere­brospinal fluid for performing a tap test in a patient with idiopathic normotensive hydrocephalus. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):148-153
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
A perspective on the application of CRISPR/CAS9 genome editing system to study of mole­cular-genetic basis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
The normal sono­graphic picture of the para­tonsillar region and the prerequisites for ultrasound diagnosis of puru­lent pathology of the pharynx. Russian Bulletin of Otorhinolaryngology. 2024;(1):4-9
Respiratory-syncitial virus: biology, gene­tic dive­rsity and perspective control preparations. Mole­cular Gene­tics, Microbiology and Viro­logy. 2024;(1):16-24
Methods of pancreatic fibrosis asse­ssment. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):48-57
Comparison of the clinical performance of immu­nochromatographic tests for the dete­ction of SARS-CoV-2 anti­gens with data from inde­pendent studies. Labo­ratory Service. 2024;(1):13-19

Objective. To study clinical symptoms of menopause depression, develop differential diagnostic criteria and consider treatment aspects. Material and methods. One hundred and fifty women, aged 41—65 years, with mental disorders developed in different periods of menopause (perimenopause, menopause and post menopause) were studied. Results and conclusion. Four types of depression were diagnosed: climacteric (n=46), psychogenic (n=35), endogenic (n=42) and involutional (n=27). Clinical characteristics of each type are presented in the aspect of correlations between psychopathological and climacteric (somatic) symptoms. Therapy of the depressions is discussed in light of literature on psychopharmacological, hormonal treatment and psychotherapy. The efficacy of antidepressants, in particular valdoxan (agomelatine), is highlighted.

Keywords:

depression
diagnosis
menopausal transition
climacteric syndrome
therapy
antidepressants

Authors:

Tiuvina N.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Pervogo Moskovskogo gosudarstvennogo universiteta im. I.M. Sechenova, Moskva

Balabanova V.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Voronina E.O.

Sechenov First Moscow State Medical University, Moscow, Russia

List of references:

  1. Serr DM, Atlas M. The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. Eds. Fioretti P., Martini L., Melis G.B., Yen S.S.C. London—New York. 1982;507-515.
  2. Smetnik VP, Tkachenko NM, Glezer GA, Moskalenko NP. Klimaktericheskii sindrom. M. 1988. (In Russ.).
  3. Smetnik VP, Kulakov VI. Rukovodstvo po klimakteriyu. M.: Meditsinskoe informatsionnoe agentstvo; 2001. (In Russ.).
  4. Whitehead M, Studd J. The Menopause. Eds. Whitehead M., Studd J. Oxford. 1988;116-129.
  5. Utian WH. Psychococial and socioeconomic burden of vasomotor symptoms in menopause: A comprehencive review. Health and Qual of Life Outcomes. 2005;3:47. doi: 10.1186/1477-7525-3-47
  6. Yureneva SV, Kamenetskaya TYa. Depressive disorders in women in peri- and postmenopausal women. Zhurn ginekol. 2007;9(2):5-12. (In Russ.).
  7. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol. 1994;29:319-336. doi: 10.1016/0531-5565(94)90012-4
  8. Tyuvina NA. Psikhicheskie narusheniya u zhenshchin v period klimakteriya. M.: Kron-press; 1996. (In Russ.).
  9. Utian WH, Serr D M. Consensus on Menopause Research. Eds. van Keep P.A., Greenblatt R.B., Albeaux-Fernet M.A. Lancaster. 1976;1-4. doi: 10.1007/978-94-011-7179-3
  10. Estrogen Effects in Psychiatric Disorders. Eds. Bergemann N., Reicher-Rössler A. Springer-Verlag. 2005;291. doi: 10.1007/b12686
  11. Schindler BA. The psychiatric disorders of midlife. Med Clin North Am. 1987;71(1):71-85. doi: 10.1016/s0025-7125(16)30883-5
  12. Schindler HPG. The Controversial Climacteric. Eds. van Keep P.A., Utian W.H., Vermeulen A. Lancaster. 1981;9-18.
  13. Tyuvina NA. Features of treatment of depressive disorders in women. Zhurn psikhiatr i psikhofarmakoter. 2008;10(3):12-15. (In Russ.).
  14. Tyuvina NA, Balabanova VV. Prevention and treatment of mental disorders of menopause. Zhurn nevropatol i psikhatr im. S.S. Korsakova. 1991;9:79-82. (In Russ.).
  15. Blumenthal SJ. Women and depression. J Womens Health Gend Based Med. 1994;3:467-479. doi: 10.1089/jwh.1994.3.467
  16. Oishi A, Mochizuki Y, Otsu R, Inaba N. Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women. Bio PsychoSocial Med. 2007;1:12-16. doi: 10.1186/1751-0759-1-12
  17. Stearns V, Isaacs C, Rowland J et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. ANN ONCOL. 2000;11:17-22.
  18. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes. JAMA. 2003;289:2827-2834. doi: 10.1001/jama.289.21.2827
  19. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578-1583.
  20. Carroll DG, Kelley KW. Use of antidepressants for management of hot flashes. Psychopharmacother. 2009;29(11):1357-1374. doi: 10.1592/phco.29.11.1357
  21. Parry BL. Optimal management of perimenopausal depression. Int J Womens Health. 2010;2:143-151. doi: 10.2147/ijwh.s7155
  22. Ware MR. Fluvoxamine: A review of the controlled trial in depression. J Clin Psychiatry. 1997;58(suppl 5):15-23.
  23. Minuzzi L, Frey BN, Soares CN. Depression During the Menopausal Transition: An Update on Epidemiology and Biological Treatments. 2012;10:1:22-27. doi: 10.1176/appi.focus.10.1.22
  24. Kennedy SH. Treating each and every depressed patient. Journal of psychopharmacology. 2008;22(suppl 7):19-23. doi: 10.1177/0269881108093270
  25. Kornstein SG, Sloan MD, Thase ME. Gender-specific differences in depression and treatment response. Psychopharmacol Bull. 2002;36(4 suppl 3):99-112.
  26. Kasper S, Corruble E, Hale A, Lemoine P, Montgomery SAF, Quera-Salva M-A. Antidepressant efficacy of agomelatine versus SSRI/SNRI results from a pooled analysis of head — to — head studies without a placebo control. International Clinical Psychopharmacology. 2013;28:12-19. doi: 10.1097/YIC.0b013e328359768e
  27. Brandon AR, Minhajuddin A, Thase ME, Jarrett RB. Impact of Reproductive Status and Age on Response of Depressed Women to Cognitive Therapy. J Womens Health (Larchmt). 2013;22(1):58-66. doi: 10.1089/jwh.2011.3427
  28. Green SM, Haber E, McCabe RE, Soares CN. Cognitive-behavioural group treatment for menopausal symptoms: a pilot study. Arch Womens Ment Health. 2013;16(4):325-332. doi: 10.1007/s00737-013-0339-x

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.